Please select the option that best describes you:

For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?

For example, for a patient on anti-CD20 therapy with low IgG or ALC levels detected on screening labs, are there values in which you would change therapy?

Please select the option that best describes you:

For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?

Related Questions